Список литературы

    1. Азнабаев М. Т., Мальханов В. Б. Аденовирусные и хламидийные заболевания глаз. – Уфа: Fилем, 1995. – 112 с.

    2. Анджелов В. О. Аденовирусные заболевания глаз. Этиология, клинико-эпидемиологические особенности, лечение и профилактика // Дисс. … докт . мед. наук. – М., 1971. – 425 с.

    3. Егоров Е. А., Алексеев В. Н., Астахов Ю. С., Бржеский В. В., Бровкина А. Ф. и др. Рациональная фармакотерапия в офтальмологии: Рук оводство для практикующих врачей. – М.: Литтерра, 2004. – 954 с.

    4. Зверев В. В., Борисенко А. С., Никонова А. А. и др. Разработка ПЦР-тест-системы для выявления аденовирусной инфекции у человека // Вопросы вирусологии. – 2005. – № 6. – С. 44-47.

    5. Каспарова Е. А. Осложненные формы аденовирусных кератоконъюнктивитов: классификация, лечение и хирургия осложнений // Глаз. – 2001. – № 5. – С. 30-34.

    6. Клещева Е. А. Острые и хронические формы аденовирусной инфекции глаз // Автореф. дисс. … канд. мед. наук. – М., 2012. – 25 с.

    7. Кетлинский С.А., Симбирцев А.С. Цитокины. – Санкт-Петербург, 2008. – 549 с.

    8. Кочергин С. А., Чернакова Г. М., Туркина К.И. и др. Клинические, диагностические и терапевтические аспекты хронической аденовирусной инфекции глаз // РМЖ. – 2013. – № 1. – С. 26–28.

    9. Майчук Д. Ю. Вирусные конъюнктивиты и кератоконъюнктивиты / В кн.: Синдром красного глаза. – Москва, 2010. – С. 31-38.

    10. Майчук Д. Ю. Патогенетическое обоснование лечения и профилактики вторичных нарушений слезообразования // Автореф. дисс. … докт. мед. наук. – М., 2005. – 24 с.

    11. Майчук Д. Ю., Григорян А. Р ., Чилингарян Л. Б. и др. Современный взгляд на течение и стадии аденовирусного конъюнктивита // Сборник научных трудов научно-практической конференции по офтальмохирургии с международным участием «Восток-Запад». – Уфа: ДизайнПолиграфСервис. – 2011. – С. 572.

    12. Майчук Ю. Ф. Вирусные заболевания глаз. – М.: Медицина, 1981. – 272 с.

    13. Майчук Ю. Ф., Гапонюк П. Я. Офтальмоферон – первый препарат интерферона в виде стабильных глазных капель // Рефракционная хирургия и офтальмология. – 2007. – Т. 4. – № 3. – С. 51.

    14. Майчук Ю. Ф. Новое в эпидемиологии и фармакотерапии глазных инфекций // РМЖ. – 2000. – № 2. – С. 48–51.

    15. Майчук Ю.Ф., Яни Е. В. Новые глазные капли интерферона “Локферон” в лечении аденовирусных заболеваний глаз // Вестник Офтальмологии. – 1999. – № 2. – С. 32–33.

    16. Майчук Ю. Ф., Яни Е. В. Оценка инновационного метода экспресс-диагностики аденовирусных заболеваний глаз с применением RPS-Аденодетектора // Российский Офтальмологический Журнал. – 2011. – № 4. – С. 1-4.

    17. Майчук Ю. Ф., Яни Е. В., Майчук Д. Ю. Препарат искусственной слезы офтагель в лечении синдрома «сухого глаза» после эпидемического кератоконъюнктивита // РМЖ. – 2001. – № 4. – С. 172–173.

    18. Мезенцева М.В. Закономерности функционирования и направленная коррекция цитокиновой регуляторной сети: Автореферат дис. ...док. мед. наук. – М. – 2006. – 43 с.

    19. Сомова В. В. Аденовирусные заболевания глаз. Некоторые аспекты клиники, диагностики, лечения // Актуальные вопросы воспалительных заболеваний глаз. – М., 2001. – С. 65–67.

    20. Шаммасова Э. Р. Конъюнктивиты в Республике Башкортостан: заболеваемость, этиологическая структура, факторы риска, диагностика // Дисс. … канд. мед. наук. – Уфа, 2006. – 140 с.

    21. Шерстюк А. И., Сакович В. Н. Изменение показателей S-Ig А в слезной жидкости в процессе лечения аденовирусных конъюнктивитов // Актуальні питання медичної науки та практики. – Запоріжжя, 2009. – С. 290-294.

    22. Южаков A. M. Основные направления в ликвидации устранимой слепоты в Российской Федерации // Ликвидация устранимой слепоты: Всемирная инициатива ВОЗ: Материалы Рос. межрегион. симпозиума (22-23 апреля 2003). – Уфа, 2003. – С. 27-31.

    23. Яни Е. В. Комплексная терапия аденовирусных офтальмоинфекций и вторичного сухого глаза // Автореф. дисс. … канд. мед. наук. – М., 2010. – 23 с.

    24. Adhikary A. K., Banik U. Human adenovirus type 8: the major agent of epidemic keratoconjunctivitis (EKC) // J Clin Virol. – 2014. – V . 61. – № 4. – Р . 477–486.

    25. Adhikary A. K., Inada T., Banik U. et al. Serological and genetic characterisation of a unique strain of adenovirus involved in an outbreak of epidemic keratoconjunctivitis // Journal of Clinical Pathology . – 2004. – V. 57. – № 4. – Р . 411-416.

    26. Akiyoshi K., Suga T., Fukui K., et al. Outbreak of epidemic keratoconjunctivitis caused by adenovirus type 54 in a nursery school in Kobe City, Japan in 2008 // Japanese Journal of Infectious Diseases. – 2011. – V. 64. – № 4. – P. 353-354.

    27. Alsuhaibani A. H., Sutphin J. E., Wagoner M. D. Confocal microscopy of subepithelial infiltrates occurring after epidemic keratoconjunctivitis // Cornea. – 2006. – V. 25. – № 9. – Р . 1102-1104.

    28. Aoki K., Kawana R., Matsumoto I., et al. Viral conjunctivitis with special reference to adenovirus type 37 and enterovirus 70 infection // Japanese Journal of Ophthalmology. – 1986. – № 30 (2). – P. 158-164.

    29. Bialasiewicz A. Adenoviral Keratoconjunctivitis // Sultan Qaboos Univ . Med. J. – 2007. – V . 7. – № 1. – Р . 15-23.

    30. Bohringer D., Birnbaum F., Reinhard T. Cyclosporin A eyedrops for keratitis nummularis after adenovirus keratoconjunctivitis // Der Ophthalmologe: Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft. – 2008. – V. 105 – №6. – Р . 592-594.

    31. Brissette-Storkus C. S., Reynolds S. M., Lepisto A. J., et al. Identification of a novel macrophage population in the normal mouse corneal stroma // Investigative Ophthalmology and Visual Science . – 2002. – V. 43. – № 7. – Р . 2264-2271.

    32. Buckwalter S. P., Teo R., Espy M. J., et al. Real-time qualitative PCR for 57 human adenovirus types from multiple specimen sources // Journal of Clinical Microbiology . – 2012. – V. 50. – № 3. – Р . 766-771.

    33. Caspi R.R., Roberge F. G. Organ-resident, nonlymphoid cells suppress proliferation of autoimmune T -helper lymphocytes // Science (New York, N.Y.). – 1987. – V. 237 – № 4818. – Р . 1029-1032.

    34. Chang S. Y., Lee C. N., Lin P. H., et al. A community-derived outbreak of adenovirus type 3 in children in Taiwan between 2004 and 2005 // Journal of Medical Virology . – 2008. – V. 80 – № 1. – Р . 102-112.

    35. Chintakuntlawar A. V ., Chodosh J. Cellular and tissue architecture of conjunctival membranes in epidemic keratoconjunctivitis // Ocular Immunology and Inflammation. – 2010. – V . 18. – № 5. – Р . 341-345.

    36. Chodosh J. Human adenovirus type 37 and the BALB/c mouse: progress toward a restricted adenovirus keratitis model (an American Ophthalmological Society thesis) // Transactions of the American Ophthalmological Society . – 2006. – V. 104. – Р . 346-365.

    37. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction // Anal Biochem. – 1987. – № 162. – Р. 156–159.

    38. Dart J. K. G., El-Amir A. N., Maddison T., et al. Identification and control of nosocomial adenovirus keratoconjunctivitis in an ophthalmi c department // The British Journal of Ophthalmology . – 2009. – V. 93. – №1. – Р . 18-20.

    39. Dosso A. A., Rungger-Brandle E. Clinical course of epidemic keratoconjunctivitis: evaluation by in vivo confocal microscopy // Cornea. – 2008. – V. 27. – № 3. – Р . 263-268.

    40. Durand M. L., Weber D.J., Rutala W.A. Healthcare-associated eye infections. Hospital epidemiology and infection control . – Philadelphia: Lippincott Williams and Wilkins, 2012. – Р . 352–64.

    41. Elnifro E.M., Cooper R. J., Klapper P. E., et al. Multiplex polymerase chain reaction for diagnosis of viral and chlamydial keratoconjunctivitis // Investigative Ophthalmology & Visual Science. – 2000. – V. 41. – № 7. – Р . 1818-1822.

    42. Ervin A. M., Wojciechowski R., Schein O. Punctal occlusion for dry eye syndrome // Cochrane Database of Systematic Reviews . – 2010. – V. 8. – № 9. – Р . 1-25.

    43. Ferguson T. A., Griffith T. S. The role of Fas ligand and TNF-related apoptosis-inducing ligand (TRAIL) in the ocular immune response // Chemical Immunology and Allergy . – 2007. – V. 92. – Р . 140–154.

    44. Forrester J. V ., Lee W . R., Kerr P . R., et al. The uveal effusion syndrome and trans-scleral flow // Eye (London, England). – 1990. – V . 4. – Pt. 2. – Р . 354-365.

    45. Forrester J. V., Xu H., Lambe T., et al. Immune privilege or privileged immunity? // Mucosal Immunology. – 2008. – V. 1. – № 5. – Р . 372-381.

    46. Forrester J. V., Dick A. D., McMenamin P. G., et al.The Eye: Basic Science in Practice. – Edinburgh: Saunders Elsevier, 2008. – Р . 398.

    47. Forrester J. V ., Xu H. Good news-bad news: The Yin and Yang of immune privilege in the eye // Frontiers in Immunology . – 2012. – № 3. – Р . 338.

    48. Forrester J. V., Xu H., Kuffova L., et al. Dendritic cell physiology and function in the eye // Immunological Reviews. – 2010. – V. 234. – № 1 – Р . 282-304.

    49. Fujino Y., Joko S., Masuda K., et al. Ciclosporin microemulsion preconcentrate treatment of patients with Behcet’s disease // Japanese Journal of Ophthalmology . – 1999. – № 43. – P. 318-326.

    50. Ghebremedhin, B. Human adenovirus: Viral pathogen with increasing importance // European Journal of Microbiology & Immunology . – 2014. – V. 4. – № 1. – Р . 26-33.

    51. Ginhoux F., Greter M., Leboeuf M., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages // Science (New York, N.Y.). – 2010. – V. 330. – № 6005. – P. 841-845.

    52. Gonzalez-Lopez J. J., Morcillo-Laiz R., Munoz-Negrete F . J. Adenoviral keratoconjunctivitis: An update // Archivos de La Sociedad Espanola de Oftalmologia. – 2013. – V. 88. – № 3. – Р . 108-115.

    53. Gottsch J. D. Surveillance and control of epidemic keratoconjunctivitis // Transactions of the American Ophthalmological Society. – 1996. – V. 94. – Р . 539-587.

    54. Gupta A. K., Sarin G. S. Serum and tear immunoglobulin levels in acute adenovirus conjunctivitis // The British Journal of Ophthalmology . – 1983. – V. 67. – № 3. – Р . 195-198.

    55. Gupta A. K., Sarin G. S. Serum complement component depression during acute adenovirus conjunctivitis // The British Journal of Ophthalmology . – 1984. – V. 68 – № 5. – Р . 350-352.

    56. Gupta A. K., Sarin G. S., Lamba P. A., et al. Immunoassay of tear lysozyme in acute adenovirus conjunctivitis // The British Journal of Ophthalmology . – 1986. – V. 70. - № 6. – Р . 439-441.

    57. Gupta A. K., Sarin G. S., Mathur M. D., et al. Alpha 1-antitrypsin and serum albumin in tear fluids in acute adenovirus conjunctivitis // The British Journal of Ophthalmology . – 1988. – V. 72. – № 5. – р. 390-393.

    58. Gupta A. K., Sarin G. S., Mathur M. D., et al. Serum beta-2 microglobulin and C-reactive protein levels in acute adenovirus conjunctivitis // Acta Ophthalmologica. – 1991. – V . 69. - № 3 – Р . 393-397.

    59. Hammer L. H., Perry H. D., Donnenfeld E. D., et al. Symblepharon formation in epidemic keratoconjunctivitis // Cornea. – 1990. – V. 9. – № 4. – Р . 338-340.

    60. Handor H., Daoudi R. Ophthalmologists beware of adenoviruses // Pan African Medical Journal. – 2014. – V. 17. – Р. 205.

    61. Harrison S. C. Virology. Looking inside adenovirus // Science (New York, N.Y.). – 2010. – V. 329. – № 5995. – Р . 1026-1027.

    62. Hattori T., Saban D. R., Emaminaeini P., et al. Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation // Journal of Leukocyte Biology . – 2012. – V. 91. – № 4. – Р . 621-627.

    63. Hillenkamp J., Reinhard T., Ross R. S., et al. The effects of cidofovir 1% with and without cyclosporin A 1% as a topical treatment of acute adenoviral keratoconjunctivitis: A controlled clinical pilot study // Ophthalmology . – 2002. – V . 109. – № 5. – р. 845-850.

    64. Hingorani M., Calder V. L., Buckley R. J., et al. The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis // Invest Ophthalmol Vis Sci. – 1999. – № 40. – P. 392-399.

    65. Hiroi S., Izumi M., Takahashi K., et al. Isolation and characterization of a novel recombinant human adenovirus species D // J Med Microbiol. – 2012. – V. 61. – № 8. – Р . 1097-1102.

    66. Holland E. J., Olsen T. W., Ketcham J. M., et al. Topical cyclosporin A in the treatment of anterior segment inflammatory disease // Cornea. – 1993. – № 12. – P. 413-419.

    67. Huang G., Yao W., Yu W., et al. Outbreak of Epidemic Keratoconjunctivitis Caused by Human Adenovirus Type 56, China, 2012 // PLoS ONE. – 2014. – V. 9. – № 10. – e110781.

    68. Jaitley S., Saraswathi T.R. Pathophysiology of Langerhans cells // J Oral Maxillofac Pathol. – 2012. – V. 16. – № 2. – P. 239-244.

    69. Janicijevic-Petrovic M. A., Sreckovic S., Petrovic N., et al. [Epidemic keratoconjunctivitis] // Srp Arh Celok Lek. – 2011. – V . 139. – № 5-6. – Р . 282-285.

    70. Jeng B. H., Holsclaw D. S. Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis // Cornea. – 2011. – V. 30. - № 9. – Р . 958-961.

    71. Jernigan J. A., Lowry B. S., Hayden F. G., et al. Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and control // The Journal of infectious diseases. – 1993. – V. 167. – № 6. – Р . 1307-1313.

    72. Jones B. R. The Clinical Features of Viral Keratitis and a Concep t of Their Pathogenesis // Proceedings of the Royal Society of Medicine . – 1958. – V. 51. – № 11. – Р . 917–924.

    73. Kaneko H., Suzutani T ., Aoki K., et al.Epidemiological and virological features of epidemic keratoconjunctivitis due to new human adenovirus type 54 in Japan // Br J Ophthalmol. – 2011. – № 95(1) – Р. 32-36.

    74. Ke Y., Sun D., Jiang G., et al.PD-L1(hi) retinal pigment epithelium (RPE) cells elicited by inflammatory cytokines induce regulatory activity in uveitogenic T cells // Journal of Leukocyte Biology . – 2010. – V. 88. – №6. – Р .1241–1249.

    75. Kiang E., Tesavibul N., Yee R., Kellaway J., et al. The use of topical cyclosporin A in ocular graft-versus-host-disease // Bone Marrow Transplant. – 1998. – № 22. – P. 147-151.

    76. Kimura R., Migita H., Kadonosono K., et al. Is it possible to detect the presence of adenovirus in conjunctiva before the onset of conjunctivitis? // Acta Ophthalmologica. – 2009. – V. 87. – № 1. – Р . 44–47.

    77. Knopf H. L., Hierholzer J. C. Clinical and immunologic responses in patients with viral keratoconjunctivitis // American Journal of Ophthalmology . – 1975. – V. 80. – №4. – Р . 661–672.

    78. Kuffova L., Netukova M., Duncan L., et al. Cross presentation of antigen on MHC class II via the draining lymph node after corneal transplantation in mice // Journal of Immunology (Baltimore, Md.: 1950). – 2008. – V. 180. – № 3. – Р . 1353–1361.

    79. Kumagai N., Fukuda K., Fujitsu Y., et al. Lipopolysaccharideinduced expression of intercellular adhesion molecule -1 and chemokines in cultured human corneal fibroblasts // Investigative Ophthalmology & Visual Science. – 2005. – V. 46. – № 1. – Р . 114–120.

    80. Kuo S.-C., Shen S.-C., Chang S.-W., et al. Corneal superinfection in acute viral conjunctivitis in young children // Journal of pediatric ophthalmology and strabismus. – 2008. – V. 45. – №6. – Р . 374–376.

    81. Laibson P. R., Dhiri S., Oconer J., et al. Corneal infiltrates in epidemic keratoconjunctivitis. Response to double-blind corticosteroid therapy // Archives of ophthalmology . – 1970. – V. 84. – №1. – Р . 36-40.

    82. Laibson P. R. Adenoviral keratoconjunctivitis // Int Ophthalm Clin. – 1975. – № 15. – P. 187-201.

    83. Lebeck M. G., McCarthy T. A., Capuano A. W., et al. Emergent US adenovirus 3 strains associated with an epidemic and serious disease // Journal of Clinical Virology – 2009. – V. 46. – №4. – Р . 331-336.

    84. Levinger E., Slomovic A., Sansanayudh W., et al.Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis // Cornea. – 2010. – V. 29. – № 6. – Р . 638-640.

    85. Lion T. Adenovirus infections in immunocompetent and immunocompromised patients // Clinical Microbiology Reviews. – 2014. – V. 27. – № 3. – Р . 441-462.

    86. Martin C. S. Latest insights on adenovirus structure and assembly // Viruses. – 2012. – V. 4. – №5. – Р . 847-77.

    87. Martin M. A., Knipe D. M., Fields B. N., et al. Fields’ virology . – Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2007. – 3177 р.

    88. Medawar P. B. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye // Br J Exp Pathol. – 1948. – Vol.29. – P.58-69.

    89. Melendez C. P., Florentino M. M., Martinez I. L., et al. Outbreak of epidemic keratoconjunctivitis caused by adenovirus in medical residents // Molecular Vision. – 2009. – V. 15. – Р . 557-562.

    90. Mena K. D., Gerba C. P. Waterborne adenovirus // Reviews of Environmental Contamination and Toxicology . – 2009. – V. 198. – Р . 133-167.

    91. Meyer-Rusenberg B., Loderstadt U., Richard G., et al. Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment // Deutsches Arzteblatt International. – 2011. – V . 108. – №27. – Р . 475-480.

    92. Murrah W . F . Epidemic keratoconjunctivitis // Ann Ophthalmol. – 1988. – V . 20. – № 1. – Р . 36-38.

    93. Natarajan K., Rajala M. S., Chodosh J. IL-8 expression following adenovirus infection is mediated by c-Src activation in human corneal fibroblasts // Journal of Immunology (Baltimore, Md.: 1950). – 2003. – V. 170. – № 12. – Р . 6234-6243.

    94. Okumus S., Coskun E., Tatar M. G., et al. Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis // BMC Ophthalmology . – 2012. – V. 12. – №1. – Р . 42.

    95. Ozturk H., Sonmez B., Beden U. Corneal sensitivity may decrease in adenoviral epidemic keratoconjunctivitis – A confocal microscopic study // Eye and Contact Lens. – 2013. – V. 39. – № 4. – Р . 264-268.

    96. Pelletier J. S., Stewart K., Trattler W., et al. A combination povidoneiodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatme nt of adenoviral conjunctivitis //Advances in Therapy . – 2009. – V. 26. – № 8. – Р . 776-783.

    97. Qiu H., Li X., Tian X., et al. Serotype-Specific Neutralizing Antibody Epitopes of Human Adenovirus Type 3 (HAdV -3) and HAdV -7 Reside in Multiple Hexon Hypervariable Regions // Journal of Virology . – 2012. – V. 86. – № 15. – Р . 7964-7975.

    98. Qureshi H., Genesca M., Fritts L., et al. Infection with host-range mutant adenovirus 5 suppresses innate immunity and induces systemic CD4+ T cell activation in rhesus macaques // PLoS One. – 2014. – V. 9. – №9. – Р . 10600.

    99. Rajaiya J., Chodosh J.New paradigms in infectious eye disease: adenoviral keratoconjunctivitis // Archivos de La Sociedad Espanola de Oftalmologia. – 2006. – V. 81. – № 9. – Р . 493-98.

    100. Reinhard T., Godehardt E., Pfahl H. G., et al. Local cyclosporin A in nummuli after keratoconjunctivitis epidemica. A pilot study // Der Ophthalmologe: Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft. – 2000. – V. 97. – № 11. – Р . 764-768.

    101. Renard G. [Adenoviral keratoconjunctivitis] // J Fr Ophtalmol. – 2010. – V. 33. – № 8. – Р . 586-592.

    102. Report M. W. Adenovirus-associated epidemic keratoconjunctivitis outbreaks-four states, 2008-2010 // MMWR. Morbidity and Mortality Weekly Report. – 2013. – V. 62. – № 32. – Р . 637–41.

    103. Romanowski E. G., Yates K. A., Gordon Y. J. Short-term treatment with a potent topical corticosteroid of an acute ocular adenoviral infection in the New Zealand white rabbit // Cornea. – 2001. – V. 20. – № 6. – Р . 657-660.

    104. Romanowski E. G., Yates K. A., Gordon Y. J. Topical corticosteroids of limited potency promote adenovirus replication in the Ad5/NZW rabbit ocular model // Cornea. – 2002. – V. 21. – №3. – Р . 289-291.

    105. Romanowski E. G., Pless P., Yates K. A., et al. Topical cyclosporine A inhibits subepithelial immune infiltrates but also promotes viral sheddi ng in experimental adenovirus models // Cornea. – 2005. – № 24(1). – P. 86-91.

    106. Romanowski E. G., Yates K. A., Gordon Y. J. The in vitro and in vivo evaluation of ddC as a topical antiviral for ocular adenovirus infections // Investigative Ophthalmology and Visual Science. – 2009. – V. 50. – №11. – Р . 5295-5299.

    107. Rowe W. P., Huebner R. J., Gilmore L. K., et al. Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culturе // Proceedings of the Society for Exp erimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). – 1953. – V. 84. – № 3. – Р . 570-573.

    108. Sambursky R., Tauber S., Schirra F., et al. The RPS Adeno Detector for Diagnosing Adenoviral Conjunctivitis // Ophthalmology . – 2006. – V. 113. – № 10. – Р. 1758-1764.

    109. Sharma P., Chawl A., Arora S., et al. Novel drug delivery approaches on antiviral and antiretroviral agents // Journal of Advanced Pharmaceutical Technology & Research. – 2012. – V. 3. – № 3. – Р . 147-159.

    110. Siamak N. M., Kowalski R. P., Thompson P. P., et al. RPS Adeno Detector // Ophthalmology . – 2009. – V. 116. – № 3 – Р . 591.

    111. Skevaki C. L., Galani I. E., Pararas M. V., et al. Treatment of viral conjunctivitis with antiviral drugs // Drugs. – 2011. – V. 71. – Р . 331-347.

    112. Sosnova M., Bradl M., Forrester J. V. CD34+ corneal stromal cells are bone marrow-derived and express hemopoietic stem cell markers // Stem Cells. – 2005. – V. 23. – № 4. – Р . 507–515.

    113. Stein-Streilein J. Immune regulation and the eye // Trends in Immunology. – 2008. – V. 29. – № 11. – Р . 548-554

    114. Sugita S., Horie S., Nakamura O., et al. Retinal pigment epithelium-derived CTLA-2alpha induces TGF-beta-producing T regulatory cells // Journal of Immunology (Baltimore, Md.: 1950). – 2008. – V. 181. – № 11. – Р . 7525-7536.

    115. Sugita S., Keino H., Futagami Y., et al. B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells // Investigative Ophthalmology and Visual Science. – 2006. – V. 47. – №12. – Р . 5376-5384.

    116. Tabbara K. F., Jarade E. F. Ganciclovir effects in adenoviral keratoconjunctivitis // ARVO. – 2001. – p. 579.

    117. Takaoka A., Wang Z., Choi M. K., et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response // Nature. – 2007. – V. 448. – № 7152. – Р . 501-505.

    118. Uchio E. New medical treatment for viral conjunctivitis // Nippon Ganka Gakkai Zasshi. – 2005. – V. 109. – № 12. – Р . 962-984.

    119. Uchio E., Fuchigami A., Kadonosono K., et al. Anti-adenoviral effect of anti-HIV agents in vitro in serotypes inducing keratoconjunctivitis // Graefe’s Archive for Clinical and Experimental Ophthalmology . – 2007. – V. 245. – № 9. – Р . 1319-1325.

    120. Uchio E., Inoue H., Fuchigami A., et al. Anti-adenoviral effect of interferon-beta and interferon-gamma in serotypes that cause acute keratoconjunctivitis // Clinical and Experimental Ophthalmology . – 2011. – V. 39. – № 4. – Р . 358-363.

    121. Uematsu S., Akira S. Pathogen recognition by innate immunity / Skin Research. – 2008. – V. 7. – № 1. – Р . 1-11.

    122. Usui Y., Okunuki Y., Hattori T., et al. Functional expression of B7H1 on retinal pigment epithelial cells // Experimental Eye Research . – 2008. – V. 86. – № 1 – Р . 52-59.

    123. Wakabayashi T., Yamashita R., Kakita T., et al. Rapid and sensitive diagnosis of adenoviral keratoconjunctivitis by loop-mediated isothermal amplification (LAMP) method // Curr Eye Res. – 2004. – V. 29. – № 4-5. – Р . 219-224.

    124. Wilkins M. R., Khan S., Bunce C., et al. A randomised placebocontrolled trial of topical steroid in presumed viral conjunctivitis // The British Journal of Ophthalmology . – 2011. – V. 95. – № 9. – Р . 1299-1303.

    125. Xiao J., Chodosh J. JNK regulates MCP-1 expression in adenovirus type 19-infected human corneal fibroblasts // Investigative Ophthalmology and Visual Science. – 2005. – V. 46. – № 10. – Р . 3777-3782.

    126. Xu H., Dawson R., Forrester J. V., et al. Identification of novel dendritic cell populations in normal mouse retina // Investigative Ophthalmology & Visual Science. – 2007. – V. 48. – №4. – р. 1701-1710.

    127. Yabiku S. T., Yabiku M. M., Bottos K. M., et al. Ganciclovir 0.15% ophthalmic gel in the treatment of adenovirus keratoconjuntivitis // Arq Bras Oftalmol. – 2011. – V. 74. – № 6. – Р . 417-421.

    128. Ying B., Tollefson A. E., Spencer J. F., et al. Ganciclovir Inhibits Human Adenovirus Replication and Pathogenicity in Permissive Immunosuppressed Syrian Hamsters // Antimicrob Agents Chemother . – 2014. – V. 58. – № 12. – Р . 7171-7181.

    129. Yoshida M., Kezuka T., Streilein J. W. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of TGF-beta-producing regulatory T cells // Investigative Ophthalmology and Visual Science. – 2000. – V. 41. – № 12. – Р . 3862-3870.

    130. Zamiri P., Sugita S., Streilein J. W. Immunosuppressive properties of the pigmented epithelial cells and the subretinal spa ce // Chemical Immunology and Allergy . – 2007. – V. 92. – Р . 86-93.

    131. Zhao J. C., Jin X. Y. Immunological analysis and treatment of Mooren’s ulcer with cyclosporin A applied topically // Cornea. – 1993. – № 12. – P. 481-488.

    132. Zhou X., Robinson C. M., Rajaiya J., et al. Analysis of human adenovirus type 19 associated with epidemic keratoconjunctivitis and its reclassification as adenovirus type 64 // Investigative Ophthalmology and Visual Science. – 2012. – V. 53. – № 6. – Р . 2804-2811.